145 results on '"Ben-Yakov, Gil"'
Search Results
2. A third dose of the BNT162b2 mRNA vaccine significantly improves immune responses among liver transplant recipients
3. Predictors of advanced liver fibrosis and the performance of fibrosis scores: lean compared to non-lean metabolic dysfunction-associated steatotic liver disease (MASLD) patients.
4. XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis
5. Extremely high peritoneal cancer index in colorectal peritoneal metastases demonstrates safety and overall survival benefit in selected patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy
6. The liver in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
7. Predictors of advanced liver fibrosis and the performance of fibrosis scores: lean compared to non-lean metabolic dysfunction-associated steatotic liver disease (MASLD) patients
8. Publisher Correction: XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis
9. Incidence rates and clinical characteristics of primary gastrointestinal non-Hodgkin lymphoma: a population study
10. Drug-Induced Liver Injury: Understanding the Different Immune-Mediated Phenotypes and Clinical Management
11. Stimulating More Than Just the Granulocytes: Drug-Induced Liver Injury From Filgrastim
12. Time to Publication for Randomized Clinical Trials Presented as Abstracts at Three Gastroenterology and Hepatology Conferences in 2017
13. Research trends analysis of chronic hepatitis C versus nonalcoholic fatty liver disease: A literature review text‐mining analysis of publications
14. Effect of Social Support on Psychological Distress and Disease Activity in Inflammatory Bowel Disease Patients
15. Postprandial Plasma Lipidomics Reveal Specific Alteration of Hepatic-derived Diacylglycerols in Nonalcoholic Fatty Liver Disease
16. A Misleading Pattern of Serologic Findings During Hepatitis B Virus Infection
17. Tip of the iceberg: A comprehensive review of liver disease in Inborn errors of immunity
18. HBV-RNA, Quantitative HBsAg, Levels of HBV in Peripheral Lymphocytes and HBV Mutation Profiles in Chronic Hepatitis B
19. The Spectrum of the Deficiency of Adenosine Deaminase 2: An Observational Analysis of a 60 Patient Cohort
20. Immunogenicity and Adverse Effects of the 2‐Dose BNT162b2 Messenger RNA Vaccine Among Liver Transplantation Recipients
21. Efficacy and long-term durability of intradermal recombinant hepatitis B virus vaccine among intramuscular vaccine nonresponders: A prospective study in healthcare personnel
22. Cryptosporidium infection in dedicator of cytokinesis 8 (DOCK 8) deficiency
23. Lipoprotein Insulin Resistance Index Reflects Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease
24. One world, one pandemic, many guidelines: management of liver diseases during COVID-19
25. Su1654 PRIMARY SCLEROSING CHOLANGITIS, STABLE IN INCIDENCE EXCEEDING IN COST - 10- YEAR US PERSPECTIVE OF TRENDS IN PSC HOSPITALIZATION CHARACTERISTICS
26. Spontaneous Clearance of Chronic Delta Hepatitis
27. Inclusion of Clinical Trial Registration Numbers in Conference Abstracts and Conformance of Abstracts to CONSORT Guidelines
28. Immunogenicity and Adverse Effects of the 2‐Dose BNT162b2 Messenger RNA Vaccine Among Liver Transplantation Recipients.
29. Liver disturbances in activated phosphoinositide 3-kinase δ syndrome
30. Facing the challenge - Providing liver care at times of pandemic
31. Longitudinal effects of Nucleos(t)ide analogue therapy in chronic hepatitis B patients and the utility of non-invasive fibrosis markers during treatment: A single-center experience for up to 17 years
32. Vibration Controlled Transient Elastography (Fibroscan®) in sickle cell liver disease ‐ could we strike while the liver is hard?
33. 504 – Liver Involvment in Dedicator of Cytokine 8 (DOCK 8) Deficiancy Syndrome – Report from a Single Center Cohort
34. 407 – The Delta-4 Score: A Novel and Clinically Useful Noninvasive Fibrosis Score for Hepatitis D
35. The Spectrum of Hepatic Involvement in Patients With Telomere Disease
36. Development of Hepatic Steatosis After Chemotherapy for Non-Hodgkin Lymphoma
37. Lipoprotein Insulin Resistance Index Reflects Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease.
38. Roadmap to resuming care for liver diseases after coronavirus disease‐2019.
39. Innumerable Liver Lesions With a More Benign Outcome: A Case Report
40. Starry Night on Liver MRI: An Unexpected Incidental Finding in a Healthy Recruit
41. Mo1491 - Fibroscan in Sickle Cell Liver Disease-Could we Strike while the Liver is Hard?
42. Tu1539 - Vibration Controlled Elastography Predicts Severity of Portal Hypertension in Non Cirrhotic Portal Hypertension
43. Su1551 - Low Skeletal Muscle Mass is Associated with Advanced Steatosis in Non Alcoholic Fatty Liver Disease
44. Tu1570 - Inflammatory Cytokines, not Disease Severity, may Provide Biological Insights into Poor Sleep Quality in Chronic Hepatitis B and C Infections
45. Sa1486 - Modeling Histologic and Biochemical Improvements of Disease Severity in Chronic Hepatitis B Patients Treated with Long Term Nucleoside Analogues for Up to 18 Years and the Utility of Non-Invasive Biomarkers
46. XCR1+type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis
47. Efficacy and safety of sequential versus quadruple therapy as second-line treatment for helicobacter pylori infection—A randomized controlled trial
48. Development of Hepatic Steatosis After Chemotherapy for Non‐Hodgkin Lymphoma.
49. Liver disturbances in activated phosphoinositide 3-kinase δ syndrome
50. Effect of psychosocial stressors on patients with Crohn’s disease: threatening life experiences and family relations
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.